Diabetes, Psychiatric Disorders, and the Metabolic Effects of Antipsychotic Medications

Abstract

IN BRIEF

Psychiatric disorders can be a risk factor for, as well as a complication of, diabetes. Antipsychotic medications, widely used to treat a variety of psychiatric conditions, are also associated with diabetes. This article explores the complex relationship among psychiatric disorders, antipsychotic medications, and risk factors for metabolic syndrome and diabetes.

Footnotes

  • Maria D. Llorente, MD, is chief of Psychiatry at the Miami VA Medical Center and a professor of psychiatry in the Department of Psychiatry and Behavioral Sciences at the University of Miami School of Medicine in Florida. Victoria Urrutia, MD, is director of Ambulatory Mental Health at the Miami VA Medical Center.

  • Note of disclosure: Dr. Llorente has received honoraria for speaking engagements from Bristol-Myers Squibb, Janssen, Forest Pharmaceuticals, Abbott Laboratories, and Astra-Zeneca and has received research support from Astra-Zeneca. These companies manufacture or market antipsychotic pharmaceutical products.

| Table of Contents